Clinical and Translational

QCI Interpret One: Oncology variant interpretation just got more precise

243 views
June 12, 2020
Competing to offer a comprehensive genomic profiling service for solid or hematology oncology tumor samples is challenging, especially as panels increase in complexity and size. QIAGEN created QCI Interpret One by combining the flexible and automatable QCI software, powered by superior structured content in the QIAGEN Clinical Knowledge Base, with the trusted services of N-of-One, a world-leading provider of somatic variant interpretation.

Lab Directors can now confidently interpret variants with variant- and disease-specific, oncologist-reviewed content. They can accelerate turnaround time by generating reports in minutes with automated classification of variant actionability and on-demand access to comprehensive expert variant interpretation without the time consuming step of researching and writing evidence-based summaries. They get access to an “expert second opinion” for variant classification, and they can deliver professional reports directly to physicians to help inform clinical decision making.

Interested in learning more?

Click here

Speakers:
Beate Litzenburger, PhD, Global Product Director of Oncology for Clinical Decision Support Software and Interpretation Services at QIAGEN
Sheryl Krevsky Elkin, PhD, Chief Scientific Officer at N-of-One, a QIAGEN company

Related videos

Clinical and Translational

Accurate and efficient interpretation with QCI Precision Insights

207 views March 20, 2020

As next-generation DNA sequencing technology continues to evolve and become...

Clinical and Translational

Cancer Gene Variant Detection Using a Pre-Optimized Sample to Report Workflow

170 views October 30, 2019

BRCA1/BRCA2 genes represent the best examples for our current understanding...

Clinical and Translational

Power up your variant knowledge using the Human Gene Mutation Database (HGMD™) Professional

214 views May 29, 2020

Through a live demonstration, discover the power of HGMD Professional and see...

Clinical and Translational

How to reduce your test turnaround for large panels in molecular oncology

201 views December 31, 2019

Speaker: Sheryl Elkin, CSO, N-of-One.a QIAGEN Company Interested in learning...